Association of dopaminergic/GABAergic genes with attention deficit hyperactivity disorder in children

Molecular Medicine Reports

Volumn 6, Issue 5, 2012, Pages 1093-1098

  Wang, Guang Xin ^a   Ma, Yan Hui ^a   Wang, Shi Fu ^a   Ren, Guang Fang ^b   Guo, Hui ^a  

^a SHANDONG UNIVERSITY   (China)

^b Shandong Province   (China)

Author keywords

Association study; Attention deficit hyperactivity disorder; Dopaminergic genes; GABAergic genes

Indexed keywords

DOPAMINE BETA MONOOXYGENASE; GENOMIC DNA;

ADOLESCENT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; COMT GENE; CONTROLLED STUDY; DBH GENE; DOPAMINERGIC SYSTEM; DRD1 GENE; DRD2 GENE; ELECTROPHORESIS; FEMALE; GABAERGIC SYSTEM; GABBR1 GENE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION MAPPING; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CATECHOL O-METHYLTRANSFERASE; CHILD; DOPAMINE BETA-HYDROXYLASE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA-B; RISK FACTORS;

EID: 84866456729     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1028     Document Type: Article

References (29)

1. Hong Q, Wang YP, Zhang M, et al: Homer expression in the hippocampus of an animal model of attention-deficit/hyperactivity disorder. Mol Med Report 4: 705-712, 2011.
2. Genro JP, Kieling C, Rohde LA and Hutz MH: Attention-deficit/ hyperactivity disorder and the dopaminergic hypotheses. Expert Rev Neurother 10: 587-601, 2010.
3. Elia J and Devoto M: ADHD genetics: 2007 update. Curr Psychiatry Rep 9: 434-439, 2007. (Pubitemid 47559365)
4. Sharp SI, Mcquillin A and Gurling HM: Genetics of attention-deficit hyperactive disorder (ADHD). Neuropharmacology 57: 590-600, 2009.
5. Gizer IR, Ficks C and Waldman ID: Candidate gene studies of ADHD: a meta-analytic review. Hum Genet 126: 51-90, 2009.
6. Kolesnichenko LS, Kulinskiǐ VI and Gorina AS: Amino acids and their metabolites in blood and urine of children with minimal cerebral dysfunction. Vopr Med Khim 45: 58-64, 1999 (In Russian).
7. Miyazaki M, Ito H, Saijo T, et al: Favorable response of ADHD with giant SEP to extended-release valproate. Brain Dev 28: 470-472, 2006.
8. Powell SG, Thomsen PH, Frydenberg M and Rasmussen H: Long-term treatment of ADHD with stimulants: a large observational study of real-life patients. J Atten Disord 15: 439-451, 2011.
9. American Psychiatric Association (APA): Diagnostic and statistical manual of mental disorders. 4th ed. American Psychiatric Press, Washington DC, 1994.
10. Li J, Kang C, Zhang H, et al: Monoamine oxidase A gene polymorphism predicts adolescent outcome of attention-deficit/hyperactivity disorder. Am J Med Genet B 144B: 430-433, 2007. (Pubitemid 46983149)
11. Barnard-Brak L, Sulak TN and Fearon DD: Coexisting disorders and academic achievement among children with ADHD. J Atten Disord 15: 506-515, 2011.
12. Domschke K, Sheehan K, Lowe N, et al: Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children. Am J Med Genet B Neuropsychiatr Genet 134B: 110-114, 2005. (Pubitemid 40416788)
13. DiMaio S, Grizenko N and Joober R: Dopamine genes and attention-deficit hyperactivity disorder: a review. J Psychiatry Neurosci 28: 27-38, 2003. (Pubitemid 36315349)
14. Fisher SE, Francks C, McCracken JT, et al: A genomewide scan for loci involved in attention-deficit/hyperactivity disorder. Am J Hum Genet 70: 1183-1196, 2002. (Pubitemid 34450569)
15. Craig SP, Buckle VJ, Lamouroux A, Mallet J and Craig IW: Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. Cytogenet Cell Genet 48: 48-50, 1988. (Pubitemid 18265296)
16. Kopecková M, Paclt I, Petrásek J, Pacltová D, Malíková M and Zagatová V: Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case-control study of 100 subjects 6-10 age. Neuro Endocrinol Lett 29: 246-251, 2008.
17. Kieling C, Genro JP, Hutz MH and Rohde LA: The -1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD. Am J Med Genet B Neuropsychiatr Genet 147B: 485-490, 2008. (Pubitemid 351830808)
18. Misener VL, Luca P, Azeke O, et al: Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder. Mol Psychiatry 9: 500-509, 2004. (Pubitemid 38903506)
19. Bobb AJ, Addington AM, Sidransky E, et al: Support for association between ADHD and two candidate genes: NET1 and DRD1. Am J Med Genet B Neuropsychiatr Genet 134B: 67-72, 2005. (Pubitemid 40411112)
20. Balk JH, Picetti R, Saiardi A, et al: Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377: 424-428, 1995.
21. Grandy DK, Litt M, Allen L, et al: The human dopamine D2 receptor gene is located on chromosome 11 at q22- q23 and identifies a TaqI RFLP. Am J Hum Genet 45: 778-785, 1989. (Pubitemid 19283787)
22. Paclt I, Drtilkova I, Kopeckova M, Theiner P, Serý O and Cermakova N: The association between TaqI A polymorphism of ANKK1 (DRD2) gene and ADHD in the Czech boys aged between 6 and 13 years. Neuro Endocrinol Lett 31: 131-136, 2010.
23. Serý O, Drtílková I, Theiner P, et al: Polymorphism of DRD2 gene and ADHD. Neuro Endocrinol Lett 27: 236-240, 2006. (Pubitemid 43970800)
24. Todd RD and Lobos EA: Mutation screening of the dopamine D2 receptor gene in attention-deficit hyperactivity disorder subtypes: preliminary report of a research strategy. Am J Med Genet 114: 34-41, 2002.
25. Pálmason H, Moser D, Sigmund J, et al: Attention-deficit/ hyperactivity disorder phenotype is influenced by a functional catechol-O-methyltransferase variant. J Neural Transm 117: 259-267, 2010.
26. Comings DE: Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders. Ann N Y Acad Sci 931: 50-83, 2001. (Pubitemid 32612781)
27. Sagvolden T, Johansen EB, Aase H and Russell VA: A dynamic developmental theory of attention-deficit/ hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci 28: 397-468, 2005.
28. Amantea D and Bowery NG: Reduced inhibitory action of a GABAB receptor agonist on [3H]-dopamine release from rat ventral tegmental area in vitro after chronic nicotine administration. BMC Pharmacol 4: 24, 2004.
29. Hossain MA and Weiner N: Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats. J Pharmacol Exp Ther 275: 237-244, 1995.